Canopy Growth Corp has faced notable challenges in the market recently, reflecting broader trends in the cannabis sector.
This week, Canopy Growth Corp (WEED.TO) experienced a decline in stock price, continuing a downward trend that has persisted throughout the year. With a focus on recent financial results and strategic developments, this overview provides insights into the company's current position and outlook.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Canopy Growth Corp
WEED.TO
WEED.TO
Canopy Growth Corp
WealthAwesomeMarket cap
$582.94M
52W high
$3.28
52W low
$1.18
1W change
-3.05%
Beta
2.42
Analyst Price Targets
Based on analyst covering WEED
Wall Street analysts forecast WEED stock price to rise 59.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.02
+59.1% Upside
Current Price
C$1.27
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on WEED's historical volatility
30-Day Vol
38.2%
Annualized
90-Day Vol
64.2%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.06
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$1.20 | C$1.05 โ C$1.37 |
| 60 trading days | C$1.13 | C$0.94 โ C$1.36 |
| 90 trading days | C$1.06 | C$0.85 โ C$1.33 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Canopy Growth's recent financial results indicate growth in specific sectors, but ongoing market pressures and stock performance may warrant cautious consideration for investors.
Canopy Growth Reports 27% Revenue Growth in Medical Cannabis
Despite a 27% increase in net revenue in the Canadian medical cannabis market, Canopy Growth's overall financial health remains under pressure with a profit margin of -92.4%.
Bull case
The acquisition of MTL Cannabis and reported revenue growth in medical and international markets could help Canopy Growth recover and expand in the future.
Bear case
Ongoing negative profit margins and a significant year-to-date decline in stock price indicate that investors should keep a close watch on the company's challenges.
Price Action Overview
This week, Canopy Growth Corp (WEED.TO) closed at C$1.27, reflecting a loss of 1.52% on the day and a total decline of 2.99% over the week. Year-to-date, the stock has dropped by 20.73%, indicating a challenging market environment for the company.
Recent Company News
Canopy Growth recently announced its financial results for Q4 and FY2026, showcasing a 27% increase in net revenue from Canadian medical cannabis and a 68% growth in international markets. Additionally, the company is set to acquire MTL Cannabis, which aims to solidify its position as a leading player in the medical cannabis sector. Furthermore, Canopy has completed a strategic recapitalization, extending the maturity of its debt obligations, which may enhance its liquidity and financial stability.
Technical Picture
From a technical perspective, Canopy Growth is currently trading below its 50-day moving average of C$1.40 and its 200-day moving average of C$1.57, indicating a bearish trend. The stock's 52-week range is C$1.18 to C$3.28, with the current price at approximately 4% of this range. The stock has a beta of 2.42, suggesting higher volatility compared to the broader market. Recent trading volume was 1,358,368 shares, which is about 0.60 times the 20-day average volume of 873,137 shares.
Advertisement
